SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-004233
Filing Date
2022-02-08
Accepted
2022-02-08 16:05:37
Documents
12
Period of Report
2022-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ktra-8k_20220204.htm   iXBRL 8-K 35635
  Complete submission text file 0001564590-22-004233.txt   163502

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ktra-20220204.xsd EX-101.SCH 5689
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20220204_lab.xml EX-101.LAB 19431
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20220204_pre.xml EX-101.PRE 11579
6 EXTRACTED XBRL INSTANCE DOCUMENT ktra-8k_20220204_htm.xml XML 3529
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 22601602
SIC: 2834 Pharmaceutical Preparations